Patents by Inventor Douglas H. Yamada

Douglas H. Yamada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11992486
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Grant
    Filed: November 17, 2022
    Date of Patent: May 28, 2024
    Assignee: Janssen Pharmaceutica NV
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Patent number: 11986468
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Grant
    Filed: November 17, 2022
    Date of Patent: May 21, 2024
    Assignee: Janssen Pharmaceutica NV
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Patent number: 11986470
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Grant
    Filed: September 13, 2023
    Date of Patent: May 21, 2024
    Assignee: Janssen Pharmaceutica NV
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Patent number: 11986469
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Grant
    Filed: November 17, 2022
    Date of Patent: May 21, 2024
    Assignee: Janssen Pharmaceutica NV
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Publication number: 20240000766
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Application
    Filed: September 13, 2023
    Publication date: January 4, 2024
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Publication number: 20230149380
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Application
    Filed: November 17, 2022
    Publication date: May 18, 2023
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Publication number: 20230098047
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Application
    Filed: November 17, 2022
    Publication date: March 30, 2023
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Publication number: 20230078160
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Application
    Filed: November 17, 2022
    Publication date: March 16, 2023
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Publication number: 20220071980
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Application
    Filed: November 16, 2021
    Publication date: March 10, 2022
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Publication number: 20220071979
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Application
    Filed: November 16, 2021
    Publication date: March 10, 2022
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Patent number: 11207311
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: December 28, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A Snyder, Douglas H Yamada
  • Publication number: 20210315986
    Abstract: Disclosed herein are PSMA and/or STEAP1 polynucleotides, polypeptides, vectors, viruses, vaccines, and vaccine combinations, and their uses.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 14, 2021
    Inventors: Marco Gottardis, Selina Khan, Manuel Alejandro Sepulveda, Douglas H. Yamada, Roland Zahn, Brent Rupnow
  • Publication number: 20190022079
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Application
    Filed: September 14, 2018
    Publication date: January 24, 2019
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A. Snyder, Douglas H. Yamada
  • Publication number: 20180028521
    Abstract: Disclosed are methods of treating prostate cancer by administering niraparib to a human in need thereof.
    Type: Application
    Filed: July 28, 2017
    Publication date: February 1, 2018
    Inventors: Marco Gottardis, Rebecca Hawkins, Linda A Snyder, Douglas H. Yamada